Franco Locatelli
IRCSS Ospedale Pediatrico Bambino Gesù · Director Department of Hematology/Oncology and Cell and Gene Therapy · IRCCS Ospedale Pediatrico Bambino Gesù, Piazza Sant'Onofrio, 4, 00165 Rome, IT
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Franco Locatelli as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:20 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07297914 · Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALLBambino Gesù Hospital and Research Institute · recruiting · Acute Lymphoblastic Leukemia (ALL), Stem Cell Transplant, Graft -Versus-host-disease · principal investigator
- Ph1NCT06080191 · Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALLBambino Gesù Hospital and Research Institute · recruiting · B-cell Acute Lymphoblastic Leukemia · principal investigator
- Ph1/Ph2NCT06064903 · CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LLBambino Gesù Hospital and Research Institute · recruiting · T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma · principal investigator
- Ph1/Ph2NCT03605212 · Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and AdultsMenarini Group · terminated · Tumor Lysis Syndrome · study chair
- Ph2NCT03055247 · Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGDIRCCS San Raffaele · recruiting · Chronic Granulomatous Disease X-linked (X-CGD) · principal investigator
- Ph4NCT02670564 · ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)Swiss Pediatric Oncology Group · unknown · Acute Lymphoblastic Leukemia · study chair
- Ph1/Ph2NCT02504619 · Allogeneic SCT of CordIn™, in Patients With HemoglobinopathiesGamida Cell ltd · terminated · Sickle Cell Disease, Thalassemia · principal investigator
- Ph2/Ph3NCT01949129 · Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic LeukaemiaSt. Anna Kinderkrebsforschung · recruiting · Acute Lymphoblastic Leukaemia · study chair
- Ph2NCT01810926 · T&B Depletion Non MalignantFranco Locatelli · unknown · Graft Versus Host Disease · principal investigator
- Ph1/Ph2NCT01810120 · Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCTMariella Enoc · completed · Acute Lymphoblastic Leukemia, Leukemia Acute Myeloid - AML, Non-Hodgkin Lymphoma · principal investigator
- Ph2/Ph3NCT00469729 · Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative TherapyGamida Cell -Teva Joint Venture Ltd. · completed · Hematologic Malignancies, Acute Myeloid Leukemia, Lymphoid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:20 UTC. The ranking covers the 200 most relevant of 292 PubMed records, and a shared surname and initials can bring in a namesake. All 292 on PubMed
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.Lancet · 20082,090 citationsRCR 52.2
- Normalization of hemoglobin level in patients with chronic kidney disease and anemia.N Engl J Med · 20061,579 citationsRCR 43.9
- 1,529 citationsRCR 48.8
- CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.N Engl J Med · 20211,491 citationsRCR 82.9
- 822 citationsRCR 22.0
- 625 citationsRCR 15.2
- Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.J Clin Oncol · 2016491 citationsRCR 15.2
- Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.N Engl J Med · 2021475 citationsRCR 29.1
- Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis.N Engl J Med · 2020452 citationsRCR 20.2
- 440 citationsRCR 13.5